ArticleJAAD case reports2026
Successful treatment of cutaneous sarcoidosis with deucravacitinib, a selective TYK2 inhibitor.
Henry O Herrera et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleJAAD case reports2026
Henry O Herrera et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.